NCT03036930 2026-03-11
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Merck Sharp & Dohme LLC
Radiation Therapy Oncology Group